Abstract:Background Polygenic risk scores (PRS) have ushered in a new era in genetic epidemiology, offering insights into individual predispositions to a wide range of diseases. However, despite recent marked enhancements in their predictive power, there are still challenges that need to be overcome before PRS-based models can be broadly applied in the clinic, including sufficient accuracy, easy interpretability and portability across diverse populations. Methods Leveraging trans-ancestry genome-wide association study (GWAS) meta-analysis, we generated novel, diverse summary statistics for 30 medically-related traits which were used to benchmark the performance of six existing PRS algorithms using UK biobank. Observing that SBayesRC had the best overall performance but recognizing strengths in each method, we developed an ensemble PRS model using logistic regression to combine outputs from top-performing algorithms. This ensemble model was validated on the diverse eMERGE and PAGE MEC cohorts, and the performance was compared against current state-of-the-art PRS models. To enhance predictive accuracy for clinical application, we incorporated easily-accessible clinical characteristics such as age, gender, ancestry and risk factors, creating disease prediction models intended as prospective diagnostic tests, with easily interpretable positive or negative outcomes. Results Predictive performance of PRS models improved with trans-ancestry GWAS meta-analysis and was further enhanced by the ensemble model, which surpassed state-of-art PRS models. When applied to external cohorts, performance drops were minimal, indicating good calibration. After adding clinical characteristics, 12 out of 30 models surpassed 80% AUC. Further, 25 traits exceeded the diagnostic odds ratio (DOR) of 5 and 19 traits exceeded DOR of 10 for all ancestry groups, indicating high predictive value. The highest DOR in a population with a sufficient number of cases was 66.2 for Alzheimer's disease in Europeans. Our PRS model for coronary artery disease identified 55-80 times more true coronary events than rare pathogenic variant models, reinforcing its clinical potential. The polygenic component modulated the effect of high-risk rare variants, stressing the need to consider all genetic components in clinical settings. Conclusions Newly developed PRS-based disease prediction models have sufficient accuracy and portability to warrant consideration of being used in the clinic.

Joint Modeling of Gene-Environment Correlations and Interactions Using Polygenic Risk Scores in Case-Control Studies

Pathway Polygenic Risk Scores (pPRS) for the Analysis of Gene-environment Interaction

Mitigating type 1 error inflation and power loss in GxE PRS: Genotype–environment interaction in polygenic risk score models

Risk assessment for colorectal cancer via polygenic risk score and lifestyle exposure: a large-scale association study of East Asian and European populations

The expected polygenic risk score (ePRS) framework: an equitable metric for quantifying polygenetic risk via modeling of ancestral makeup

Predicting the status of human complex diseases with random forest and polygenic risk scores

Identifying and characterizing disease subpopulations that most benefit from polygenic risk scores

A Machine Learning Model for Disease Risk Prediction by Integrating Genetic and Non-Genetic Factors

JointPRS: A Data-Adaptive Framework for Multi-Population Genetic Risk Prediction Incorporating Genetic Correlation

Estimation of Direct and Indirect Polygenic Effects and Gene-Environment Interactions using Polygenic Scores in Case-Parent Trio Studies

Optimization of Multi-Ancestry Polygenic Risk Score Disease Prediction Models

Methodologies underpinning polygenic risk scores estimation: a comprehensive overview

How to improve polygenic prediction from whole-genome sequencing data by leveraging predicted epigenomic features?

Optimizing and benchmarking polygenic risk scores with GWAS summary statistics

A data-adaptive Bayesian regression approach for polygenic risk prediction

Are gene-by-environment interactions leveraged in multi-modality neural networks for breast cancer prediction?

Bregman Divergence-Based Data Integration with Application to Polygenic Risk Score (PRS) Heterogeneity Adjustment

Combined Associations of a Polygenic Risk Score and Classical Risk Factors with Breast Cancer Risk

Implementing polygenic risk scores in the clinic

A comprehensive investigation of statistical and machine learning approaches for predicting complex human diseases on genomic variants

Systems biology approaches to utilise polygenic risk scores for chronic diseases